Navigation Links
Silence Therapeutics Announces Issuance of Japanese Patent for Screening Therapeutics Against Key Pathway Associated with Cancer and Other Diseases
Date:9/16/2011

tential partners with a strong proprietary position in the RNAi therapeutics space. The Company expects to make significant further progress in reinforcing its patent portfolio during 2011. At present, Silence's global patent portfolio contains issued patents and pending applications covering strategic areas of RNAi therapeutic development. These include multiple proprietary siRNA delivery technologies, potent siRNA sequences specific for high-value disease targets and chemical modifications.

Notes for editors

About Silence Therapeutics plc (http://www.silence-therapeutics.com)

Silence Therapeutics plc (AIM: SLN) is a leading biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. Silence offers one of the most comprehensive short interfering RNA (siRNA) therapeutic platforms available today based on a strong intellectual property portfolio and large clinical safety database. Silence's clinical siRNA product pipeline is one of the broadest in the industry. The Company possesses multiple proprietary siRNA delivery technology platforms including AtuPLEX™ and DACC. AtuPLEX enables the broad functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. The DACC delivery system allows functional delivery of siRNA molecules selectively to the lung endothelium with a long duration of target mRNA and protein knock-down. Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequence
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
2. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
3. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
4. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
5. Silence Therapeutics Provides Year-end Update
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
8. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Silence Therapeutics Announces Board Changes
11. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/27/2015)... Va. , Aug. 27, 2015  The ... the Food and Drug Administration,s (FDA,s) draft guidance ... reference products and biosimilars, to bear a nonproprietary ... AMCP has been seeking a decision from the ... 18 diverse health care stakeholders urging the agency ...
(Date:8/27/2015)... , August 27, 2015 According to a ... Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), ... to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is ... Million in 2015, at a CAGR of 11.4 % from 2015 ... ma rket data T ables and ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
(Date:8/28/2015)... ... 2015 , ... Saint Petersburg, FL —Pocket Protein™, a protein ... sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that never ... Choice Awards. , Five consumer packaged goods (CPG) products were selected by the ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery is ... and only nonsurgical product approved by the Food and Drug Administration to eliminate submental ... Dr. William Koenig are among the premier cosmetic surgeons in Rochester to ...
(Date:8/28/2015)... ... 28, 2015 , ... SharkNinja, an innovative leader in the ... actress, Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the ... a variety of sizes and styles while achieving the perfect brew richness level ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... PARIS and MARSEILLE, France, January 11 ... signing of a,scientific collaboration agreement in the breast cancer domain. ... Ipsogen,s,MapQuant Dx Grade Genomic, HER2 and HR tests will be ... patients treated at the Institut,Curie. The aim of this collaboration ...
... , CHICAGO, Jan. 11 ... Stimulus Program , making it safe and easy for physicians ... qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... a guarantee that the Allscripts EHR they select will meet ...
... , , ... MDRX ) announced today that Renaissance Medical Management Company (RMMC) ... Practice Management solution to automate and connect clinical and ... medicine physicians. The new service offering from RMMC builds upon the ...
... ... months and shared his story on ABC,s Good Morning America on January 8, 2010 , ... New York, NY (PRWEB) January 11, 2010 -- ... ago, kicked off 2010 with an appearance on ABC,s Good Morning America last Friday, feeling and ...
... ... simply spelling correctly the Hebrew word Sun ( SheMeSh éÞé) in English Letters as ... ... years of research, Joseph Lanyadoo concludes that language was neither invented by humans ...
... , CHICAGO, Jan. 10 Allscripts-Misys Healthcare ... for the three and six months ended November 30, 2009. ... Highlights: , Total revenue of $169.3 million; non-GAAP ... cents; non-GAAP earnings per share of $0.16 cents Net income ...
Cached Medicine News:Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 2Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 2Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 4Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 5Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 2Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 3Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 4Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 5Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 7Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 2Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 2Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 13Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 14Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 15Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 16Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 17Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 18
... flexible care settings., ,IntelliVue MP40 ... and measurement flexibility to match the ... care environmentsat the patients side., ... patient monitoring, IntelliVue has highly flexible ...
... Built on Philips strong heritage in patient ... an extensive clinical measurements menu; built-in clinical ... derived 12-lead ECG, and arrhythmia analysis; and ... easy to use and operates on a ...
... to match the pace and unique needs ... on Philips strong heritage in patient monitoring, ... has highly flexible screen configuration; an extensive ... such as Event Surveillance, EASI derived 12-lead ...
... expands hospital-grade monitoring capabilities into the growing ... disease state management. The system is ... full range of clinical applications, from continuous ... to periodic monitoring of patients outside the ...
Medicine Products: